IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q2 2021 Holdings

Filed 2021-08-16 | 8 holdings | $15.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$15.5M569,04198.5%
Karuna Therapeutics IncCOM48576A100$97.2K852,7080.6%
Vaxcyte Inc(PCVX)COM92243G108$31.6K1,405,4210.2%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$29.2K1,891,4670.2%
Inozyme Pharma IncCOM45790W108$27.1K1,591,1540.2%
Akouos IncCOM00973J101$22.5K1,794,0880.1%
Aligos Therapeutics IncCOM01626L105$17.9K876,5480.1%
Fusion Pharmaceuticals IncCOM36118A100$12.6K1,598,3770.1%